Should Canopy Growth Corp. Be a Top Pick for 2018?

Canopy Growth Corp. (TSX:WEED) has enjoyed a stellar 2017. Are more gains on the way next year?

| More on:

Canopy Growth Corp. (TSX:WEED) has been a profitable pick for investors this year, and those who’ve missed out on the big rally are wondering if more gains could be on the way in 2018.

Let’s take a look at the current situation to see if the stock deserves to be in your portfolio.

Medical marijuana leader

Canopy is the leader in Canada’s medical marijuana market. The company has done a good job of making strategic acquisitions at opportune times, including the purchase of Mettrum Health earlier this year.

Canopy currently provides medical marijuana to more than 50,000 registered patients through its online sales platform. The company offers several brands and has negotiated deals with smaller suppliers to give them access to the market through its CraftGrow program.

The move is a smart one, as it helps Canopy secure its dominant position. Smaller companies do not have the resources to build their own online platform, and by allowing other producers to use its system, Canopy gets a piece of the action while controlling the point of sale.

The company is also positioning itself for international growth. Canopy already owns a pharmaceutical distributor in Germany and has entered joint-venture, or partnership, agreements in several countries, including Spain, Australia, Denmark, Brazil, Jamaica, and Chile.

Recreational opportunities

Canopy’s stock has rallied on the hopes that Canada will open its recreational marijuana market next summer.

The federal government appears determined to follow through with its schedule, and the provinces are slowly revealing blueprints for how they plan to run the industry in their respective jurisdictions.

Ottawa has placed the majority of the burden on the provinces, so most of the details on pricing and distribution have to be sorted out at the provincial level.

Whether or not the provinces will be able to hit the ground running on July 1, 2018, is yet to be seen, but investors seem to think the odds are pretty good.

Canopy also received a boost after Constellation Brands, which owns Corona, announced an agreement to take a 9.9% stake in the marijuana producer.

Constellation plans to sell cannabis-infused beverages in markets that allow the recreational use of marijuana.

Should you buy for 2018?

At the time of writing, Canopy trades for $19.20 per share. That’s nearly triple the price some investors paid for the stock in early June, and translates into a market capitalization of more than $3.65 billion.

Based on the company’s most recent quarter, the stock is very expensive. Canopy reported revenue of $17.6 million and a net loss of $1.6 million.

As a result, investors who buy today have to be convinced the recreational market will open as planned, and the company will capture a significant part of that market, which pundits say is worth at least $5 billion.

Management is doing all the right things, and Canopy could very well grow into its valuation quite quickly. However, given the large rally in the past six months, I would probably wait for a pullback before adding the stock to your portfolio.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

Business success with growing, rising charts and businessman in background
Dividend Stocks

5 TSX Stocks With High Dividend Growth to Buy Now

These TSX stocks sport a high dividend growth rate and are known for consistently rewarding their shareholders with increased cash.

Read more »

Various Canadian dollars in gray pants pocket
Dividend Stocks

Canadian Blue-Chip Stocks: The Best of the Best for May 2024

These two blue-chip stocks are up in 2023, sure, but have seen even more growth in the last few decades.…

Read more »

Couple relaxing on a beach in front of a sunset
Dividend Stocks

Passive Income: How to Make $33 Per Month Tax-Free by Doing Nothing

Hold monthly paying dividend stocks such as Exchange Income in your TFSA to begin a tax-free stream of passive income…

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

What’s Going on With Canadian Pot Stocks?

Canadian cannabis stocks exposed to the U.S. saw a boost in share price this week from rumours that rescheduling of…

Read more »

Target. Stand out from the crowd
Tech Stocks

CGI Stock: A Heavy-Hitter That Just Jumped 4%

Shares of CGI stock (TSX:GIB.A) rose after seeing stronger results that put the acquisition tech stock back on the top…

Read more »

A plant grows from coins.
Energy Stocks

Say Goodbye to Volatility With Rock-Solid, Stable Low Beta Stocks

Hydro One (TSX:H) stock is a great volatility fighter for income investors seeking stability on the TSX.

Read more »

data analyze research
Dividend Stocks

Is Telus Stock a Buy on a Dip?

Telus is down more than 20% over the past year and now offers a great dividend yield.

Read more »

A plant grows from coins.
Dividend Stocks

2 Top Dividend-Growth Stocks to Buy in May

These two dividend stocks saw major growth after earnings that promised more was coming in the future. And now could…

Read more »